Rasha Al-Lamee, MA, MD, PhD

Interventional Cardiology Consultant
Imperial College London
London, England, United Kingdom

Dr Rasha Al-Lamee is an Interventional Cardiologist at Imperial College Healthcare NHS Trust and a Clinical Senior Lecturer at Imperial College London. She is a British Heart Foundation intermediate clinical research fellow with expertise in coronary intervention, invasive physiology and invasive intravascular imaging.

She designed, conducted and led the ORBITA trial. She leads a research group at the National Heart and Lung Institute. She is the chief investigator of the ORBITA-2, ORBITA-STAR, ORBITA-COSMIC and ORBITA-FIRE trials, has over 100 peer-reviewed publications and a h-index of 32.

She is a deputy editor at EuroIntervention and an associate editor at the European Heart Journal. She is the NIHR CRN North West London Cardiovascular speciality lead, co-head of the cardiovascular theme of the Imperial Biomedical Research Centre and Phase 1c lead for clinical medicine at Imperial College London.

Presentation(s):

• Coronary Physiology Trends in 2023

  Saturday, February 25, 2023
  1:10 PM – 1:25 PM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• Questions and Closing Comments

  Saturday, February 25, 2023
  1:55 PM – 2:00 PM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• Ischemia with and Without Visible CAD – What’s Going On?

  Saturday, February 25, 2023
  4:48 PM – 4:56 PM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• Panel Discussion: Cardiovascular Microvascular Dysfunction

  Saturday, February 25, 2023
  5:36 PM – 5:50 PM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• LATE-BREAKING TRIALS | SESSION ONE

  Saturday, February 25, 2023
  4:30 PM – 5:30 PM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• CALCIFIED LESIONS AND BEYOND

  Sunday, February 26, 2023
  11:15 AM – 12:30 PM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• Panel Discussion | Should All High-Risk PCI Consider MCS?

  Sunday, February 26, 2023
  12:19 PM – 12:30 PM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• LETS GET READY TO RUMBLE - CONTROVERSIES IN INTERVENTIONAL CARDIOLOGY (NON-CME) - SPONSORED BY MEDTRONIC

  Monday, February 27, 2023
  9:00 AM – 10:00 AM ET

  Disclosure information not submitted.

• Revascularization in Stable Ischemic Cardiomyopathy – The REVIVED BCIS Study

  Monday, February 27, 2023
  9:01 AM – 9:08 AM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• WHY DOES CALCIUM MATTER? LESION PREPARATION IN A NUTSHELL

  Monday, February 27, 2023
  10:00 AM – 11:00 AM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• Panel Discussion

  Monday, February 27, 2023
  10:40 AM – 11:00 AM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• ALL YOU NEED TO KNOW ABOUT BIFURCATION LESIONS AND MORE

  Monday, February 27, 2023
  11:00 AM – 12:00 PM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• Panel Discussion

  Monday, February 27, 2023
  11:40 AM – 12:00 PM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• Live Case from Mount Sinai Hospital | New York, NY

  Monday, February 27, 2023
  2:00 PM – 2:45 PM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• PCI 2023: CONTROVERSIES AND HOT TOPICS IN INTERVENTIONAL CARDIOLOGY

  Monday, February 27, 2023
  4:30 PM – 5:33 PM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• Where Do We Stand with Medical Therapy Versus Intervention in Stable Patients with Ischemia

  Monday, February 27, 2023
  4:53 PM – 5:01 PM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

• Complex Coronary Interventions | Tuesday Session

  Tuesday, February 28, 2023
  9:00 AM – 1:00 PM ET

  Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)